Wednesday, December 19, 2012

Merck KGaA cancer drug Stimuvax fails late-stage trial

Retweeted Medical News (@MedicalNews): Merck KGaA cancer drug Stimuvax fails late-stage trial http://t.co/DyEY3Yf6

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/DyEY3Yf6

No comments:

Post a Comment